8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-1.92%
Negative gross profit growth while 3391.T is at 5.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.60%
Negative EBIT growth while 3391.T is at 13.27%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.40%
Negative operating income growth while 3391.T is at 11.64%. Joel Greenblatt would press for urgent turnaround measures.
-3.10%
Negative net income growth while 3391.T stands at 15.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.10%
Negative EPS growth while 3391.T is at 15.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.10%
Negative diluted EPS growth while 3391.T is at 15.17%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-42.18%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-72.49%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
20.90%
10Y CAGR of 20.90% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
20.90%
5Y CAGR of 20.90% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
20.90%
3Y CAGR of 20.90% while 3391.T is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
89.60%
10Y net income/share CAGR of 89.60% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
89.60%
Net income/share CAGR of 89.60% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
89.60%
3Y net income/share CAGR of 89.60% while 3391.T is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.